StandardStandard

Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica. / Okoro, T.; Tafazal, S.; Longworth, S. et al.
Yn: Journal of Spinal Disorders and Techniques, Cyfrol 23, Rhif 1, 01.02.2010, t. 74-77.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Okoro, T, Tafazal, S, Longworth, S & Sell, P 2010, 'Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica.', Journal of Spinal Disorders and Techniques, cyfrol. 23, rhif 1, tt. 74-77. https://doi.org/10.1097/BSD.0b013e31819afdc4

APA

CBE

MLA

VancouverVancouver

Okoro T, Tafazal S, Longworth S, Sell P. Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica. Journal of Spinal Disorders and Techniques. 2010 Chw 1;23(1):74-77. doi: 10.1097/BSD.0b013e31819afdc4

Author

Okoro, T. ; Tafazal, S. ; Longworth, S. et al. / Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica. Yn: Journal of Spinal Disorders and Techniques. 2010 ; Cyfrol 23, Rhif 1. tt. 74-77.

RIS

TY - JOUR

T1 - Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica.

AU - Okoro, T.

AU - Tafazal, S.

AU - Longworth, S.

AU - Sell, P.

PY - 2010/2/1

Y1 - 2010/2/1

U2 - 10.1097/BSD.0b013e31819afdc4

DO - 10.1097/BSD.0b013e31819afdc4

M3 - Article

VL - 23

SP - 74

EP - 77

JO - Journal of Spinal Disorders and Techniques

JF - Journal of Spinal Disorders and Techniques

SN - 0301-620X

IS - 1

ER -